Chemometrics-assisted simultaneous determination of atenolol and chlorthalidone in synthetic binary mixtures and pharmaceutical dosage forms View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2003-09-03

AUTHORS

Mónica C. F. Ferraro, Patricia M. Castellano, Teodoro S. Kaufman

ABSTRACT

Resolution of binary mixtures of atenolol (ATE) and chlorthalidone (CTD) with minimum sample pre-treatment and without analyte separation has been successfully achieved, using a new and rapid method based on partial least squares (PLS1) analysis of UV spectral data. The simultaneous determination of both analytes was possible by PLS1 processing of sample absorbances between 255 and 300 nm for ATE and evaluation of absorbances in the 253–268 nm region for CTD. The mean recoveries for synthetic samples were 100.3±1.0% and 100.7±0.7% for ATE and CTD, respectively. Application of the proposed method to two commercial tablet preparations in the content uniformity test showed them to contain 103.5±0.8% and 104.9±1.8% ATE respectively, as well as 103.4±1.2% and 104.5±2.2% CTD. Use of this method also allowed the elaboration of dissolution profiles of the drugs in two commercial combined formulation products, through the simultaneous determination of both drugs during the dissolution test. At the dissolution time of 45 min specified by USP XXIV, both pharmaceutical formulations complied with the test. More... »

PAGES

1159-1164

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00216-003-2185-6

DOI

http://dx.doi.org/10.1007/s00216-003-2185-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1026649535

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/12955392


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/03", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Chemical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0301", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Analytical Chemistry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Algorithms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antihypertensive Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Atenolol", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Calibration", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chlorthalidone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Combinations", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Reproducibility of Results", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Spectrophotometry, Ultraviolet", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tablets", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Area An\u00e1lisis de Medicamentos, Facultad de Ciencias Bioqu\u00edmicas y Farmac\u00e9uticas, Universidad Nacional de Rosario, Suipacha 531, S2002LRK, Rosario, Argentina", 
          "id": "http://www.grid.ac/institutes/grid.10814.3c", 
          "name": [
            "Area An\u00e1lisis de Medicamentos, Facultad de Ciencias Bioqu\u00edmicas y Farmac\u00e9uticas, Universidad Nacional de Rosario, Suipacha 531, S2002LRK, Rosario, Argentina"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ferraro", 
        "givenName": "M\u00f3nica C. F.", 
        "id": "sg:person.01054240204.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01054240204.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Area An\u00e1lisis de Medicamentos, Facultad de Ciencias Bioqu\u00edmicas y Farmac\u00e9uticas, Universidad Nacional de Rosario, Suipacha 531, S2002LRK, Rosario, Argentina", 
          "id": "http://www.grid.ac/institutes/grid.10814.3c", 
          "name": [
            "Area An\u00e1lisis de Medicamentos, Facultad de Ciencias Bioqu\u00edmicas y Farmac\u00e9uticas, Universidad Nacional de Rosario, Suipacha 531, S2002LRK, Rosario, Argentina"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Castellano", 
        "givenName": "Patricia M.", 
        "id": "sg:person.01143531226.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143531226.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Instituto de Qu\u00edmica Org\u00e1nica de S\u00edntesis -IQUIOS-(CONICET-UNR), Suipacha 531, S2002LRK, Rosario, Argentina", 
          "id": "http://www.grid.ac/institutes/grid.10814.3c", 
          "name": [
            "Area An\u00e1lisis de Medicamentos, Facultad de Ciencias Bioqu\u00edmicas y Farmac\u00e9uticas, Universidad Nacional de Rosario, Suipacha 531, S2002LRK, Rosario, Argentina", 
            "Instituto de Qu\u00edmica Org\u00e1nica de S\u00edntesis -IQUIOS-(CONICET-UNR), Suipacha 531, S2002LRK, Rosario, Argentina"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kaufman", 
        "givenName": "Teodoro S.", 
        "id": "sg:person.0635546504.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0635546504.26"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s002160050607", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031289314", 
          "https://doi.org/10.1007/s002160050607"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1018975002025", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008368655", 
          "https://doi.org/10.1023/a:1018975002025"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-94-017-1026-8_5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000847385", 
          "https://doi.org/10.1007/978-94-017-1026-8_5"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2003-09-03", 
    "datePublishedReg": "2003-09-03", 
    "description": "Resolution of binary mixtures of atenolol (ATE) and chlorthalidone (CTD) with minimum sample pre-treatment and without analyte separation has been successfully achieved, using a new and rapid method based on partial least squares (PLS1) analysis of UV spectral data. The simultaneous determination of both analytes was possible by PLS1 processing of sample absorbances between 255 and 300\u00a0nm for ATE and evaluation of absorbances in the 253\u2013268\u00a0nm region for CTD. The mean recoveries for synthetic samples were 100.3\u00b11.0% and 100.7\u00b10.7% for ATE and CTD, respectively. Application of the proposed method to two commercial tablet preparations in the content uniformity test showed them to contain 103.5\u00b10.8% and 104.9\u00b11.8% ATE respectively, as well as 103.4\u00b11.2% and 104.5\u00b12.2% CTD. Use of this method also allowed the elaboration of dissolution profiles of the drugs in two commercial combined formulation products, through the simultaneous determination of both drugs during the dissolution test. At the dissolution time of 45\u00a0min specified by USP XXIV, both pharmaceutical formulations complied with the test.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00216-003-2185-6", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1358693", 
        "issn": [
          "1618-2642", 
          "1618-2650"
        ], 
        "name": "Analytical and Bioanalytical Chemistry", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7-8", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "377"
      }
    ], 
    "keywords": [
      "simultaneous determination", 
      "pharmaceutical dosage forms", 
      "synthetic binary mixtures", 
      "binary mixtures", 
      "analyte separation", 
      "synthetic samples", 
      "pharmaceutical formulations", 
      "dissolution profiles", 
      "UV spectral data", 
      "dissolution test", 
      "dosage forms", 
      "USP XXIV", 
      "commercial tablet preparations", 
      "formulation products", 
      "mean recovery", 
      "spectral data", 
      "dissolution time", 
      "content uniformity test", 
      "sample absorbance", 
      "absorbance", 
      "rapid method", 
      "tablet preparations", 
      "determination", 
      "mixture", 
      "minimum sample", 
      "analytes", 
      "partial least squares analysis", 
      "separation", 
      "preparation", 
      "least squares analysis", 
      "samples", 
      "products", 
      "atenolol", 
      "uniformity test", 
      "method", 
      "drugs", 
      "XXIV", 
      "squares analysis", 
      "applications", 
      "formulation", 
      "recovery", 
      "chlorthalidone", 
      "elaboration", 
      "min", 
      "form", 
      "resolution", 
      "analysis", 
      "time", 
      "use", 
      "profile", 
      "test", 
      "processing", 
      "evaluation", 
      "region", 
      "data", 
      "PLS1 processing", 
      "evaluation of absorbances", 
      "Chemometrics-assisted simultaneous determination"
    ], 
    "name": "Chemometrics-assisted simultaneous determination of atenolol and chlorthalidone in synthetic binary mixtures and pharmaceutical dosage forms", 
    "pagination": "1159-1164", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1026649535"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00216-003-2185-6"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "12955392"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00216-003-2185-6", 
      "https://app.dimensions.ai/details/publication/pub.1026649535"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-11-01T18:06", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/article/article_372.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00216-003-2185-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00216-003-2185-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00216-003-2185-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00216-003-2185-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00216-003-2185-6'


 

This table displays all metadata directly associated to this object as RDF triples.

184 TRIPLES      22 PREDICATES      96 URIs      85 LITERALS      16 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00216-003-2185-6 schema:about N2b46a4c5592249b989e743ce3b3be90b
2 N2d3008db4d1b4da691216019a2106999
3 N2ec4a15bca0449c090df1f4162dd1f25
4 N3dd70638be594e1380da9c22bc9fd8bb
5 N425298a9e06d49c2b4554620eb9ab132
6 N78f6202aa9a742c9ab37daee5736691b
7 N83af9fca6f614e68a798669603245340
8 Nc5f9279817ce4fd4bbd8b8340ae5bfe5
9 Nd10435c613954c63b424ec638cafe074
10 anzsrc-for:03
11 anzsrc-for:0301
12 schema:author Na58df5bfbceb4bbba83e08045d88d135
13 schema:citation sg:pub.10.1007/978-94-017-1026-8_5
14 sg:pub.10.1007/s002160050607
15 sg:pub.10.1023/a:1018975002025
16 schema:datePublished 2003-09-03
17 schema:datePublishedReg 2003-09-03
18 schema:description Resolution of binary mixtures of atenolol (ATE) and chlorthalidone (CTD) with minimum sample pre-treatment and without analyte separation has been successfully achieved, using a new and rapid method based on partial least squares (PLS1) analysis of UV spectral data. The simultaneous determination of both analytes was possible by PLS1 processing of sample absorbances between 255 and 300 nm for ATE and evaluation of absorbances in the 253–268 nm region for CTD. The mean recoveries for synthetic samples were 100.3±1.0% and 100.7±0.7% for ATE and CTD, respectively. Application of the proposed method to two commercial tablet preparations in the content uniformity test showed them to contain 103.5±0.8% and 104.9±1.8% ATE respectively, as well as 103.4±1.2% and 104.5±2.2% CTD. Use of this method also allowed the elaboration of dissolution profiles of the drugs in two commercial combined formulation products, through the simultaneous determination of both drugs during the dissolution test. At the dissolution time of 45 min specified by USP XXIV, both pharmaceutical formulations complied with the test.
19 schema:genre article
20 schema:inLanguage en
21 schema:isAccessibleForFree false
22 schema:isPartOf N6df6e9f3c36a48489e4a1954dc446694
23 Ne70cf59b7b714f1e8ed8e10f6b9907c3
24 sg:journal.1358693
25 schema:keywords Chemometrics-assisted simultaneous determination
26 PLS1 processing
27 USP XXIV
28 UV spectral data
29 XXIV
30 absorbance
31 analysis
32 analyte separation
33 analytes
34 applications
35 atenolol
36 binary mixtures
37 chlorthalidone
38 commercial tablet preparations
39 content uniformity test
40 data
41 determination
42 dissolution profiles
43 dissolution test
44 dissolution time
45 dosage forms
46 drugs
47 elaboration
48 evaluation
49 evaluation of absorbances
50 form
51 formulation
52 formulation products
53 least squares analysis
54 mean recovery
55 method
56 min
57 minimum sample
58 mixture
59 partial least squares analysis
60 pharmaceutical dosage forms
61 pharmaceutical formulations
62 preparation
63 processing
64 products
65 profile
66 rapid method
67 recovery
68 region
69 resolution
70 sample absorbance
71 samples
72 separation
73 simultaneous determination
74 spectral data
75 squares analysis
76 synthetic binary mixtures
77 synthetic samples
78 tablet preparations
79 test
80 time
81 uniformity test
82 use
83 schema:name Chemometrics-assisted simultaneous determination of atenolol and chlorthalidone in synthetic binary mixtures and pharmaceutical dosage forms
84 schema:pagination 1159-1164
85 schema:productId N2babc582984a4b2789280e7e287a83b2
86 N55eea71a945b40339f8edcf3e8600dc5
87 N74d3cd3cd19b4a70a9f3a1914261d59d
88 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026649535
89 https://doi.org/10.1007/s00216-003-2185-6
90 schema:sdDatePublished 2021-11-01T18:06
91 schema:sdLicense https://scigraph.springernature.com/explorer/license/
92 schema:sdPublisher N7d44d3574dc1439eb2cb1b133cafe6bc
93 schema:url https://doi.org/10.1007/s00216-003-2185-6
94 sgo:license sg:explorer/license/
95 sgo:sdDataset articles
96 rdf:type schema:ScholarlyArticle
97 N2b46a4c5592249b989e743ce3b3be90b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Tablets
99 rdf:type schema:DefinedTerm
100 N2babc582984a4b2789280e7e287a83b2 schema:name doi
101 schema:value 10.1007/s00216-003-2185-6
102 rdf:type schema:PropertyValue
103 N2d3008db4d1b4da691216019a2106999 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Atenolol
105 rdf:type schema:DefinedTerm
106 N2ec4a15bca0449c090df1f4162dd1f25 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Antihypertensive Agents
108 rdf:type schema:DefinedTerm
109 N3dd70638be594e1380da9c22bc9fd8bb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Reproducibility of Results
111 rdf:type schema:DefinedTerm
112 N425298a9e06d49c2b4554620eb9ab132 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Chlorthalidone
114 rdf:type schema:DefinedTerm
115 N4b499da7531a419f8e8fd826652f8adc rdf:first sg:person.01143531226.30
116 rdf:rest N7010057c575640e792135ed3d6956d6c
117 N55eea71a945b40339f8edcf3e8600dc5 schema:name pubmed_id
118 schema:value 12955392
119 rdf:type schema:PropertyValue
120 N6df6e9f3c36a48489e4a1954dc446694 schema:issueNumber 7-8
121 rdf:type schema:PublicationIssue
122 N7010057c575640e792135ed3d6956d6c rdf:first sg:person.0635546504.26
123 rdf:rest rdf:nil
124 N74d3cd3cd19b4a70a9f3a1914261d59d schema:name dimensions_id
125 schema:value pub.1026649535
126 rdf:type schema:PropertyValue
127 N78f6202aa9a742c9ab37daee5736691b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Calibration
129 rdf:type schema:DefinedTerm
130 N7d44d3574dc1439eb2cb1b133cafe6bc schema:name Springer Nature - SN SciGraph project
131 rdf:type schema:Organization
132 N83af9fca6f614e68a798669603245340 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Algorithms
134 rdf:type schema:DefinedTerm
135 Na58df5bfbceb4bbba83e08045d88d135 rdf:first sg:person.01054240204.80
136 rdf:rest N4b499da7531a419f8e8fd826652f8adc
137 Nc5f9279817ce4fd4bbd8b8340ae5bfe5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Drug Combinations
139 rdf:type schema:DefinedTerm
140 Nd10435c613954c63b424ec638cafe074 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Spectrophotometry, Ultraviolet
142 rdf:type schema:DefinedTerm
143 Ne70cf59b7b714f1e8ed8e10f6b9907c3 schema:volumeNumber 377
144 rdf:type schema:PublicationVolume
145 anzsrc-for:03 schema:inDefinedTermSet anzsrc-for:
146 schema:name Chemical Sciences
147 rdf:type schema:DefinedTerm
148 anzsrc-for:0301 schema:inDefinedTermSet anzsrc-for:
149 schema:name Analytical Chemistry
150 rdf:type schema:DefinedTerm
151 sg:journal.1358693 schema:issn 1618-2642
152 1618-2650
153 schema:name Analytical and Bioanalytical Chemistry
154 schema:publisher Springer Nature
155 rdf:type schema:Periodical
156 sg:person.01054240204.80 schema:affiliation grid-institutes:grid.10814.3c
157 schema:familyName Ferraro
158 schema:givenName Mónica C. F.
159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01054240204.80
160 rdf:type schema:Person
161 sg:person.01143531226.30 schema:affiliation grid-institutes:grid.10814.3c
162 schema:familyName Castellano
163 schema:givenName Patricia M.
164 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143531226.30
165 rdf:type schema:Person
166 sg:person.0635546504.26 schema:affiliation grid-institutes:grid.10814.3c
167 schema:familyName Kaufman
168 schema:givenName Teodoro S.
169 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0635546504.26
170 rdf:type schema:Person
171 sg:pub.10.1007/978-94-017-1026-8_5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000847385
172 https://doi.org/10.1007/978-94-017-1026-8_5
173 rdf:type schema:CreativeWork
174 sg:pub.10.1007/s002160050607 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031289314
175 https://doi.org/10.1007/s002160050607
176 rdf:type schema:CreativeWork
177 sg:pub.10.1023/a:1018975002025 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008368655
178 https://doi.org/10.1023/a:1018975002025
179 rdf:type schema:CreativeWork
180 grid-institutes:grid.10814.3c schema:alternateName Area Análisis de Medicamentos, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Suipacha 531, S2002LRK, Rosario, Argentina
181 Instituto de Química Orgánica de Síntesis -IQUIOS-(CONICET-UNR), Suipacha 531, S2002LRK, Rosario, Argentina
182 schema:name Area Análisis de Medicamentos, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Suipacha 531, S2002LRK, Rosario, Argentina
183 Instituto de Química Orgánica de Síntesis -IQUIOS-(CONICET-UNR), Suipacha 531, S2002LRK, Rosario, Argentina
184 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...